HomeCompareRMED vs GBDC

RMED vs GBDC: Dividend Comparison 2026

RMED yields 336.70% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RMED wins by $3317.05M in total portfolio value
10 years
RMED
RMED
● Live price
336.70%
Share price
$0.59
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3337.83M
Annual income
$2,106,889,629.77
Full RMED calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — RMED vs GBDC

📍 RMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMEDGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMED + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMED pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMED
Annual income on $10K today (after 15% tax)
$28,619.53/yr
After 10yr DRIP, annual income (after tax)
$1,790,856,185.30/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, RMED beats the other by $1,776,925,311.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMED + GBDC for your $10,000?

RMED: 50%GBDC: 50%
100% GBDC50/50100% RMED
Portfolio after 10yr
$1679.30M
Annual income
$1,061,639,446.59/yr
Blended yield
63.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

RMED
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Altman Z
-31.7
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMED buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMEDGBDC
Forward yield336.70%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$3337.83M$20.78M
Annual income after 10y$2,106,889,629.77$16,389,263.41
Total dividends collected$3218.78M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: RMED vs GBDC ($10,000, DRIP)

YearRMED PortfolioRMED Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$44,370$33,670.03$12,490$1,790.28+$31.9KRMED
2$187,097$139,620.61$16,522$3,157.73+$170.6KRMED
3$750,420$550,226.83$23,578$5,898.68+$726.8KRMED
4$2,865,463$2,062,513.01$37,115$11,886.75+$2.83MRMED
5$10,426,475$7,360,429.85$66,136$26,423.57+$10.36MRMED
6$36,186,404$25,030,075.51$137,257$66,491.44+$36.05MRMED
7$119,906,417$81,186,964.99$341,734$194,868.54+$119.56MRMED
8$379,719,698$251,419,831.96$1,050,788$685,133.02+$378.67MRMED
9$1,150,408,903$744,108,826.12$4,099,314$2,974,971.01+$1146.31MRMED
10$3,337,827,156$2,106,889,629.77$20,775,530$16,389,263.41+$3317.05MRMED

RMED vs GBDC: Complete Analysis 2026

RMEDStock

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Full RMED Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this RMED vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMED vs SCHDRMED vs JEPIRMED vs ORMED vs KORMED vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.